NEW YORK, NY -- (MARKET WIRE) -- October 11, 2006 -- Mazal Plant Pharmaceuticals Inc. (PINKSHEETS: MZPP) (FRANKFURT: M9J) (“Mazal”) announced today that Richard Serbin, who has served as Patent attorney for Schering Plough Corporation, Chief FDA Counsel for Revlon Corporation and Johnson and Johnson Corporation, President of Bradley Pharmaceuticals and founder of Radius Scientific Corporation, has been appointed as head of Mazal’s Business Advisory Board. Mr. Serbin will play an active role in developing business strategy and joint venture contacts and in guiding the company in regulatory compliance and investor relations.
